MIRO Miromatrix Medical Price Target

NASDAQ:MIRO   Miromatrix Medical Inc
Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.

Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the function of a bioengineered liver in humans via an external application.

if it succeeds, the opportunity to buy the stock at these prices will be history.
The Market Cap of MIRO is just 214.74Mil

On 7/19/2021 Craig Hallum brokerage Initiated Coverage with a Buy rating and a $22.00 price target

BUYSELL indicators:
1 Minute Scalping
BYBIT $30K Bonus:

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.